Company News

REVISE: Galderma To Meet with FDA About Rx-to-OTC Acne Switch

Kline & Co. delves into forces and trends shaping this growing category.

Author Image

By: Christine Esposito

Editor-in-Chief

Galderma Laboratories, L.P. has submitted an application to the FDA in support of the over-the-counter (OTC) marketing of adapalene gel 0.1%, currently a prescription drug.   According to Kline & Company, this could be game changer for the acne category, which is crowded with various skin care brands and products ranging from OTC acne medications to facial treatments to prescription acne medications.   Recording nearly 7% growth in 2014, the market for acne medications in the United Sta...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters